Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05979285Not ApplicableCompleted

MEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and Application

Role: lead

NCT03883230Completed

Wound Infection Detection Evaluation, WIDE

Role: lead

NCT03167060Not ApplicableCompleted

BrainCool-Migraine Intranasal Cooling Trial

Role: lead

NCT02375789Not ApplicableTerminated

Intranasal Cooling for Symptomatic Relief of Migraine

Role: lead

NCT01898455Not ApplicableCompleted

Intranasal Cooling for Cluster Headache and Migraine

Role: lead

All 5 trials loaded